Download video

Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug

1.9K views

Yahoo Finance

3 years ago

Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug

Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug

Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug
3:03
Coronavirus treatment: Roche, Regeneron team up to make COVID-19 antibody drug
by Yahoo Finance
Regeneron CEO on teaming up with Roche to develop Covid-19 antibody cocktail
4:45
Regeneron CEO on teaming up with Roche to develop Covid-19 antibody cocktail
by CNBC Television
Coronavirus treatment: Regeneron announces 2-part cocktail therapy to reduce recovery time
3:24
Coronavirus treatment: Regeneron announces 2-part cocktail therapy to reduce recovery time
by Yahoo Finance
Roche, Regeneron link up on antibodies
1:04
Roche, Regeneron link up on antibodies
by Reuters
Regeneron's science chief on starting clinical trials for Covid-19 antibody drug
5:32
Regeneron's science chief on starting clinical trials for Covid-19 antibody drug
by CNBC Television
Regeneron begins COVID-19 antibody therapy testing
9:08
Regeneron begins COVID-19 antibody therapy testing
by Yahoo Finance
W.H.O. backs antibody treatment Regeneron for high-risk COVID patients | ANC
3:25
W.H.O. backs antibody treatment Regeneron for high-risk COVID patients | ANC
by ANC 24\/7
FDA Approves Regeneron’s Covid-19 Antibody Treatment | NBC Nightly News
2:29
FDA Approves Regeneron’s Covid-19 Antibody Treatment | NBC Nightly News
by NBC News
Significance of Regeneron antibody cocktail: Former FDA chief Scott Gottlieb
1:59
Significance of Regeneron antibody cocktail: Former FDA chief Scott Gottlieb
by CNBC Television
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
5:19
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
by CNBC Television
Dr. Scott Gottlieb says he's surprised Trump used Regeneron cocktail instead of Remdesivir treatment
4:21
Dr. Scott Gottlieb says he's surprised Trump used Regeneron cocktail instead of Remdesivir treatment
by CNBC Television
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
11:49
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
by Zero To Finals
Regeneron science chief to begin testing coronavirus antibody treatment this summer
10:39
Regeneron science chief to begin testing coronavirus antibody treatment this summer
by CNBC Television
Coronavirus: Regeneron co-founder talks about President Trump's antibody treatment
3:46
Coronavirus: Regeneron co-founder talks about President Trump's antibody treatment
by Global News
Roche Expects Deliveries of Covid-19 Antibody in First Quarter
5:23
Roche Expects Deliveries of Covid-19 Antibody in First Quarter
by Bloomberg Television
Regeneron chief scientist explains promising results for Covid-19 antibody cocktail
3:11
Regeneron chief scientist explains promising results for Covid-19 antibody cocktail
by CNBC Television
Regeneron Co-Founder on Monoclonal Antibody Treatment
18:35
Regeneron Co-Founder on Monoclonal Antibody Treatment
by WebMD
Regeneron receives $450 million federal contract for Covid-19 antibody drug
1:08
Regeneron receives $450 million federal contract for Covid-19 antibody drug
by CNBC Television
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
2:32
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
by CNBC Television
Regeneron CEO on how antibody cocktail may protect against Covid-19
6:08
Regeneron CEO on how antibody cocktail may protect against Covid-19
by CNBC Television
Regeneron CEO on distribution of Covid-19 antibody cocktail
2:55
Regeneron CEO on distribution of Covid-19 antibody cocktail
by CNBC Television
Regeneron president on Covid antibody cocktail efficacy and supply chain
3:53
Regeneron president on Covid antibody cocktail efficacy and supply chain
by CNBC Television
Regeneron says its COVID-19 drug cut patient visits
1:57
Regeneron says its COVID-19 drug cut patient visits
by Reuters